Cargando…

Y-box binding protein 1 augments sorafenib resistance via the PI3K/Akt signaling pathway in hepatocellular carcinoma

BACKGROUND: Sorafenib is the first-line treatment for patients with advanced hepatocellular carcinoma (HCC). Y-box binding protein 1 (YB-1) is closely correlated with tumors and drug resistance. However, the relationship between YB-1 and sorafenib resistance and the underlying mechanism in HCC remai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ting, Xie, Xiao-Li, Zhou, Xue, Chen, Sheng-Xiong, Wang, Yi-Jun, Shi, Lin-Ping, Chen, Shu-Jia, Wang, Yong-Juan, Wang, Shu-Ling, Zhang, Jiu-Na, Dou, Shi-Ying, Jiang, Xiao-Yu, Cui, Ruo-Lin, Jiang, Hui-Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326262/ https://www.ncbi.nlm.nih.gov/pubmed/34366628 http://dx.doi.org/10.3748/wjg.v27.i28.4667

Ejemplares similares

Prostaglandin F(2α) synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F(2α)-dependent and F(2α)-independent mechanism
por: Wang, Yi-Jun, et al.
Publicado: (2023)

Qingjie Fuzheng granules inhibit colorectal cancer cell growth by the PI3K/AKT and ERK pathways
por: Yang, Hong, et al.
Publicado: (2019)

Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma via the PI3K/AKT pathway
por: Hu, Dong-Xin, et al.
Publicado: (2022)

Physcion increases the sensitivity of hepatocellular carcinoma to sorafenib through miRNA-370/PIM1 axis-regulated glycolysis
por: Pan, Xiao-Ping, et al.
Publicado: (2023)

Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways
por: Cui, Shu-Xiang, et al.
Publicado: (2016)

MicroRNA-92b augments sorafenib resistance in hepatocellular carcinoma via targeting PTEN to activate PI3K/AKT/mTOR signaling
por: Cheng, Zhouyang, et al.
Publicado: (2021)

LINC01268 promotes epithelial-mesenchymal transition, invasion and metastasis of gastric cancer via the PI3K/Akt signaling pathway and targeting MARCKS
por: Tang, Ling-Han, et al.
Publicado: (2023)

PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma
por: Wang, Pusen, et al.
Publicado: (2020)

Decreased expression of the long non-coding RNA HOXD-AS2 promotes gastric cancer progression by targeting HOXD8 and activating PI3K/Akt signaling pathway
por: Yao, Lin, et al.
Publicado: (2020)

MAEL Augments Cancer Stemness Properties and Resistance to Sorafenib in Hepatocellular Carcinoma through the PTGS2/AKT/STAT3 Axis
por: Shi, Chaoran, et al.
Publicado: (2022)

FNDC5 Causes Resistance to Sorafenib by Activating the PI3K/Akt/Nrf2 Pathway in Hepatocellular Carcinoma Cells
por: Liu, Huayuan, et al.
Publicado: (2022)

XB130 inhibits healing of diabetic skin ulcers through the PI3K/Akt signalling pathway
por: Zhu, Xin-Lin, et al.
Publicado: (2023)

Bone marrow mesenchymal stem cell-derived exosomal microRNAs target PI3K/Akt signaling pathway to promote the activation of fibroblasts
por: Li, Fang-Qi, et al.
Publicado: (2023)

MicroRNA-101 inhibits growth and metastasis of human ovarian cancer cells by targeting PI3K/AKT
por: Wei, Min, et al.
Publicado: (2019)

Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells
por: Zhang, Yafei, et al.
Publicado: (2012)

PAQR3 inhibits proliferation via suppressing PI3K/AKT signaling pathway in non-small cell lung cancer
por: Li, Xiaohui, et al.
Publicado: (2017)

Ketamine exhibits anti-gastric cancer activity via induction of apoptosis and attenuation of PI3K/Akt/mTOR
por: Zhao, Shiling, et al.
Publicado: (2019)

Renin-angiotensin system inhibitor attenuates oxidative stress induced human coronary artery endothelial cell dysfunction via the PI3K/AKT/mTOR pathway
por: Shi, Xuekun, et al.
Publicado: (2018)

miR-3682-3p directly targets FOXO3 and stimulates tumor stemness in hepatocellular carcinoma via a positive feedback loop involving FOXO3/PI3K/AKT/c-Myc
por: Chen, Qian, et al.
Publicado: (2022)

Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway
por: Li, Na, et al.
Publicado: (2021)

Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling
por: Zhang, P-F, et al.
Publicado: (2016)

High mobility group box-1 release from H(2)O(2)-injured hepatocytes due to sirt1 functional inhibition
por: Ye, Ting-Jie, et al.
Publicado: (2019)

Inhibitory effect of oxymatrine on hepatocyte apoptosis via TLR4/PI3K/Akt/GSK-3β signaling pathway
por: Zhang, Xian, et al.
Publicado: (2017)

MiR-30e-3p inhibits gastric cancer development by negatively regulating THO complex 2 and PI3K/AKT/mTOR signaling
por: Gu, Xiao-Jing, et al.
Publicado: (2022)

shRNA-interfering LSD1 inhibits proliferation and invasion of gastric cancer cells via VEGF-C/PI3K/AKT signaling pathway
por: Pan, Hong-Ming, et al.
Publicado: (2019)

Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma
por: Pan, Long, et al.
Publicado: (2020)

CTHRC1 facilitates bladder cancer cell proliferation and invasion through regulating the PI3K/Akt signaling pathway
por: Li, Yubing, et al.
Publicado: (2019)

Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway
por: Wu, Li-Mei, et al.
Publicado: (2021)

Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells
por: Liao, Li-Zhu, et al.
Publicado: (2020)

Fibroblast-derived CXCL12/SDF-1α promotes CXCL6 secretion and co-operatively enhances metastatic potential through the PI3K/Akt/mTOR pathway in colon cancer
por: Ma, Jia-Chi, et al.
Publicado: (2017)

Signal transducer and activator of transcription 3 promotes the Warburg effect possibly by inducing pyruvate kinase M2 phosphorylation in liver precancerous lesions
por: Bi, Yang-Hui, et al.
Publicado: (2019)

Embryonic liver fordin is involved in glucose glycolysis of hepatic stellate cell by regulating PI3K/Akt signaling
por: Tu, Wei, et al.
Publicado: (2016)

Forkhead Box q1 promotes invasion and metastasis in colorectal cancer by activating the epidermal growth factor receptor pathway
por: Zhang, Jin-Jin, et al.
Publicado: (2022)

Vascular endothelial growth factor B inhibits insulin secretion in MIN6 cells and reduces Ca(2+) and cyclic adenosine monophosphate levels through PI3K/AKT pathway
por: Jia, Jing-Dan, et al.
Publicado: (2021)

Impact of sorafenib on epidural fibrosis: An immunohistochemical study
por: Tanriverdi, Osman, et al.
Publicado: (2018)

Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer in vitro
por: Chen, Jiang, et al.
Publicado: (2017)

Sestrin 2 confers primary resistance to sorafenib by simultaneously activating AKT and AMPK in hepatocellular carcinoma
por: Dai, Jimin, et al.
Publicado: (2018)

High spindle and kinetochore-associated complex subunit-3 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma
por: Zheng, Lin-Lin, et al.
Publicado: (2023)

Dickkopf-related protein 1/cytoskeleton-associated protein 4 signaling activation by Helicobacter pylori-induced activator protein-1 promotes gastric tumorigenesis via the PI3K/AKT/mTOR pathway
por: Luo, Mei, et al.
Publicado: (2022)

Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K−Akt/p-HDAC6 Signaling Pathway
por: Wu, Hongxian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_73ko65de75ars67cj2l22bu87o